A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo
Clinical Trial Information
Trial Contact: Jobson, Gillian S; Jarquin-Castillo, Katherine ; Durand, Jennifer
The main purpose of this study is to learn if the usual chemotherapy given before surgery (neoadjuvant therapy) for breast cancer plus the experimental drug, atezolizumab, is better than the usual chemotherapy plus a placebo.
18 Years and older with Triple Negative Breast Cancer Diagnosed by Core Needle Biopsy and Confirmed on Central Testing